Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on September 15, 2021. The filing addresses a material legal development regarding a wrongful death lawsuit originally filed in April 2017 against the Company and its former subsidiary, Biostage, Inc.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a legal contingency and insurance coverage dispute.
Material Changes and Legal Developments
- Insurance Coverage Denial: On September 15, 2021, a liability insurance carrier notified the Company that it is denying coverage for the wrongful death lawsuit and will cease providing a defense or covering legal expenses incurred after September 30, 2021.
- Declaratory Judgment: The insurance carrier has filed a complaint for declaratory judgment seeking a court ruling that it is not required to defend or indemnify the Company or Biostage.
- Underlying Lawsuit: The case involves allegations of terminal injuries caused by a synthetic trachea scaffold and bioreactors used in surgeries in Europe in 2012 and 2013. The plaintiff seeks an unspecified amount of damages.
Outlook, Risks, and Management Commentary
- Management Stance: The Company believes the insurance carrier's grounds for denial are without merit and intends to vigorously defend against the declaratory judgment to restore insurance rights.
- Financial Impact Risk: If the Company loses the underlying case, damages could be substantial. There is no assurance that insurance will reimburse defense costs or damages.
- Indemnification Uncertainty: While Biostage has agreed to indemnify the Company for certain liabilities, the Company notes uncertainty regarding Biostage's ability to satisfy these obligations due to its overall financial condition.
- Recovery Options: The Company is evaluating potential malpractice claims as a source of recovery but has not yet asserted such a claim.
Investor Verification Checklist
- Verify the current financial condition of Biostage, Inc., to assess the viability of its indemnification obligations.
- Monitor the status of the declaratory judgment lawsuit filed by the insurance carrier.
- Review the Company's cash reserves and liquidity to determine the ability to fund legal defense costs without insurance coverage.
- Track any updates regarding the potential assertion of malpractice claims against third-party surgeons.